Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseRobert Zeiser, Gèrard Socié, Nikolas von Bubnoff et al.|New England Journal of Medicine|2020Cited by 859
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cellsRobert Zeiser, Robert S. Negrin|Blood|2007Cited by 393
Immune modulatory effects of oncogenic KRAS in cancerShaima’a Hamarsheh, Robert Zeiser|Nature Communications|2020Cited by 373
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damageLukas Schwab, Robert Zeiser, Roland Mertelsmann et al.|Nature Medicine|2014Cited by 294
The Nlrp3 inflammasome regulates acute graft-versus-host diseaseDragana Janković, Robert Zeiser|The Journal of Experimental Medicine|2013Cited by 233